Correction to: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus.

Lambert, Catherine;Dubois, Benedicte;Dive, Dominique;Lysandropoulos, Andreas;Janssens, Ann;et.al.
(2018) Acta Neurologica Belgica — Vol. 118, n° 1, p. 141 (2018)

Files

2018_Lambert_Acta_Neurol_Belg_Erratum.pdf
  • Restricted Access
  • Adobe PDF
  • 496.76 KB
Request a copy

Details

Authors
Show more
Abstract
The article Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus, written by Lambert et al., was originally published electronically on the publisher's internet portal on 27 January 2018 without open access.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Lambert, C., Dubois, B., Dive, D., Lysandropoulos, A., Selleslag, D., Vanopdenbosch, L., Van Pesch, V., Vanwijmeersch, B., & Janssens, A. (2018). Correction to: Management of immune thrombocytopenia in multiple sclerosis patients treated with alemtuzumab: a Belgian consensus. Acta Neurologica Belgica, 118(1), 141. https://doi.org/10.1007/s13760-018-0899-7 (Original work published 2018)